대한핵의학회지 (1967년~2009년)
Nucl Med Mol Imaging 2009;43(6)582~587
재발한 악성 갈색세포종 환자에서 131I-Metaiodobenzylguanidine (131I-MIBG) 치료 후 131I-MIBG와 18F-FDG PET/CT 영상의 차이점
(A Discrepancy between 131I-Metaiodobenzylguanidine (131I-MIBG) Scintigraphy and 18F-FDG PET/CT after 131I-MIBG Therapy in a Patient with Recurred Malignant Pheochromocytoma)
Author 김근호, 김성민, 서영덕,
Kun-Ho Kim, M.D., Seong-Min Kim, M.D., Ph.D., and Young-Duk Seo, M.D.
Affiliation 충남대학병원 핵의학과
Department of Nuclear Medicine, Chungnam National University Hospital, Daejeon, Korea.
Abstract

A 59-year-old woman who was diagnosed with malignant pheochromocytoma underwent 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT). She had undergone left adrenalectomy for pheochromocytoma 4 years previously. Recent multiple metastatic pulmonary nodules were noted on the chest X-ray. After treatment with 131I-metaiodobenzylguanidine (131I-MIBG) with 7.4 GBq, post-therapy 131I-MIBG scintigraphy depicted multiple distant metastases including lung, liver, abdominal para-aortic and mesenteric lymph nodes. 18F-FDG PET/CT also depicted multiple metastases in lung, liver, and abdominal para-aortic lymph nodes, but some lesions were not shown. In this case, 131I-MIBG scintigraphy found additional lesions in metastatic malignant pheochromocytoma.

Keyword Malignant pheochromocytoma, 131I-metaiodobenzylguanidine (131I-MIBG), 18F-FDG PET/CT
Full text Article 4306582587.pdf 4306582587.pdf
(03121)서울시 종로구 지봉로 29 금호팔레스빌딩 1705호
TEL : 02-745-2040 FAX : 02-745-3833 E-mail : ksnm@ksnm.or.kr
Copyright 2012 by The Korean Society of Nuclear Medicine(KSNM)